In 1963, on the site of the old Lever Brothers soap factory, MIT opened the first building in a modern office complex known as Technology Square. The utilitarian structure would house MIT’s computing pioneers for more than four decades. Its construction also represented a first step in turning Kendall Square into a hotbed of innovation.
The transformation came in fits and starts. Not long after Tech Square debuted, NASA opened its Electronics Research Center at 55 Broadway, only to move out three years later because of federal budget cuts. Cambridge paved over much of the large parcel of land cleared for the space agency and began the slow process of courting developers. Although Draper Laboratory, which had spun out of MIT, moved into Tech Square in 1976, many companies left the city, lured by suburban office parks. So it was big news in 1980 that Boston Properties would break ground on the first office building in the new Cambridge Center development.
In the 1980s, the Kendall Square biotech revolution began. Biogen moved into a warehouse on Binney Street in 1983. The Whitehead Institute, which would help lead the Human Genome Project, arrived in 1984, followed by Genzyme in 1990. Today, the corner of Vassar and Main is a nexus of the life sciences, with the Broad Institute, the McGovern Institute for Brain Research, the Picower Institute for Learning and Memory, the Koch Institute for Integrative Cancer Research, the Whitehead, and Novartis all within shouting distance.
In the late 1990s and 2000s, Kendall Square became the home of high-tech startups like Akamai and lured tech stalwarts like Microsoft and Google. Today many of the nearly 600 startups at the Cambridge Innovation Center at One Broadway are tech companies.Meanwhile, more than 50 Kendall restaurants have opened since 1990. And if MIT’s plan to add housing, retail, office, and R&D space gets approved by the Cambridge Planning Board, can a grocery store be far behind?
This new data poisoning tool lets artists fight back against generative AI
The tool, called Nightshade, messes up training data in ways that could cause serious damage to image-generating AI models.
The Biggest Questions: What is death?
New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.
Rogue superintelligence and merging with machines: Inside the mind of OpenAI’s chief scientist
An exclusive conversation with Ilya Sutskever on his fears for the future of AI and why they’ve made him change the focus of his life’s work.
How to fix the internet
If we want online discourse to improve, we need to move beyond the big platforms.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.